• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测 11 种小儿丙泊酚输注用于长时间麻醉的药代动力学模型的预测性能。

Predictive performance of eleven pharmacokinetic models for propofol infusion in children for long-duration anaesthesia.

机构信息

Department of Anaesthesia, Chiba Children's Hospital, Heta-cho 579-1, Midori-ku, Chiba, Chiba, 266-0007, Japan.

Department of Anaesthesiology, National Defense Medical College, Namiki 3-2, Tokorozawa, Saitama 359-8513, Japan.

出版信息

Br J Anaesth. 2017 Mar 1;118(3):415-423. doi: 10.1093/bja/aex007.

DOI:10.1093/bja/aex007
PMID:28186264
Abstract

BACKGROUND

Predictive performance of eleven published propofol pharmacokinetic models was evaluated for long-duration propofol infusion in children.

METHODS

Twenty-one aged three-11 yr ASA I-II patients were included. Anaesthesia was induced with propofol or sevoflurane, and maintained with propofol, remifentanil, and fentanyl. Propofol was continuously infused at rates of 4-14 mg kg  - 1 h - 1 after an initial bolus of 1.5-2.0 mg kg  - 1 . Venous blood samples were obtained every 30-60 min for five h and then every 60-120 min after five h from the start of propofol administration, and immediately after the end of propofol administration. Model performance was assessed with prediction error (PE) derivatives including divergence PE, median PE (MDPE), and median absolute PE (MDAPE) as time-related PE shift, measures for bias, and inaccuracy, respectively.

RESULTS

We collected 85 samples over 270 (130) (88-545), mean (SD) (range), min. The Short model for children, and the Schüttler general-purpose model had acceptable performance (-20%≤MDPE ≤ 20%, MDAPE ≤ 30%, -4% h - 1  ≤   divergence PE ≤ 4% h - 1 ). The Short model showed the best performance with the maximum predictive performance metric. Two models developed only using bolus dosing (Shangguan and Saint-Maurice models) and the Paedfusor of the remaining nine models had significant negative divergence PE (≤-6.1% h - 1 ).

CONCLUSIONS

The Short model performed well during continuous infusion up to 545 min. This model might be preferable for target-controlled infusion for long-duration anaesthesia in children.

摘要

背景

评估了 11 种已发表的丙泊酚药代动力学模型在儿童长时间丙泊酚输注中的预测性能。

方法

纳入 21 名 ASA I-II 级 3-11 岁的患者。麻醉诱导采用丙泊酚或七氟醚,维持采用丙泊酚、瑞芬太尼和芬太尼。丙泊酚初始剂量为 1.5-2.0mg/kg,然后以 4-14mg/kg·h -1 的速度持续输注。静脉血样在丙泊酚给药后每 30-60min 采集一次,前 5h 每 60-120min 采集一次,然后在给药结束后立即采集。通过预测误差(PE)衍生物评估模型性能,包括发散性 PE、中位数 PE(MDPE)和中位数绝对 PE(MDAPE),分别作为时间相关的 PE 偏移、偏差和不准确性的度量。

结果

我们共采集了 85 个样本,时间为 270(130)(88-545)min,均值(SD)(范围),min。儿童专用的 Short 模型和 Schüttler 通用模型表现出可接受的性能(-20%≤MDPE≤20%,MDAPE≤30%,-4% h -1 ≤发散性 PE≤4% h -1 )。Short 模型的预测性能指标最大,表现出最佳性能。仅使用负荷剂量开发的两个模型(Shangguan 和 Saint-Maurice 模型)和其余 9 个模型中的 Paedfusor 模型的发散性 PE 显著为负(≤-6.1% h -1 )。

结论

Short 模型在持续输注长达 545min 时表现良好。该模型可能更适合儿童长时间麻醉的靶控输注。

相似文献

1
Predictive performance of eleven pharmacokinetic models for propofol infusion in children for long-duration anaesthesia.预测 11 种小儿丙泊酚输注用于长时间麻醉的药代动力学模型的预测性能。
Br J Anaesth. 2017 Mar 1;118(3):415-423. doi: 10.1093/bja/aex007.
2
The performance of compartmental and physiologically based recirculatory pharmacokinetic models for propofol: a comparison using bolus, continuous, and target-controlled infusion data.隔室和基于生理的丙泊酚再循环药代动力学模型的性能:使用推注、连续和靶控输注数据的比较。
Anesth Analg. 2010 Aug;111(2):368-79. doi: 10.1213/ANE.0b013e3181bdcf5b. Epub 2009 Oct 27.
3
Performance evaluation of paediatric propofol pharmacokinetic models in healthy young children.健康幼儿中儿童丙泊酚药代动力学模型的性能评估。
Br J Anaesth. 2011 Oct;107(4):593-600. doi: 10.1093/bja/aer198. Epub 2011 Jul 9.
4
Predictive performance of computer-controlled infusion of remifentanil during propofol/remifentanil anaesthesia.丙泊酚/瑞芬太尼麻醉期间瑞芬太尼计算机控制输注的预测性能
Br J Anaesth. 2003 Feb;90(2):132-41. doi: 10.1093/bja/aeg046.
5
Predictive accuracy of continuous propofol infusions in neurosurgical patients: comparison of pharmacokinetic models.丙泊酚持续输注在神经外科患者中的预测准确性:药代动力学模型比较
J Neurosurg Anesthesiol. 1997 Apr;9(2):112-7. doi: 10.1097/00008506-199704000-00002.
6
Performance of computer-controlled infusion of propofol: an evaluation of five pharmacokinetic parameter sets.丙泊酚计算机控制输注的性能:五种药代动力学参数集的评估
Anesth Analg. 1995 Dec;81(6):1275-82. doi: 10.1097/00000539-199512000-00026.
7
Assessment of the performance of the Marsh model in effect site mode for target controlled infusion of propofol during the maintenance phase of general anaesthesia in an unselected population of neurosurgical patients.在未选择的神经外科手术患者群体中,评估Marsh模型在效应室模式下用于全身麻醉维持期丙泊酚靶控输注的性能。
Eur J Anaesthesiol. 2013 Oct;30(10):627-32. doi: 10.1097/EJA.0b013e328363157a.
8
The predictive ability of six pharmacokinetic models of rocuronium developed using a single bolus: evaluation with bolus and continuous infusion regimen.使用单次推注建立的六种罗库溴铵药代动力学模型的预测能力:推注和持续输注方案的评估
J Anesth. 2016 Aug;30(4):620-7. doi: 10.1007/s00540-016-2174-5. Epub 2016 Apr 20.
9
Clinical adaptation of a pharmacokinetic model of Propofol plasma concentrations in children.儿童丙泊酚血药浓度药代动力学模型的临床应用
Paediatr Anaesth. 2008 Mar;18(3):235-9. doi: 10.1111/j.1460-9592.2007.02407.x. Epub 2008 Jan 7.
10
Evaluation of the predictive performance of a pharmacokinetic model for propofol in Japanese macaques (Macaca fuscata fuscata).日本猕猴(食蟹猕猴指名亚种)中丙泊酚药代动力学模型预测性能的评估。
J Vet Pharmacol Ther. 2013 Apr;36(2):169-73. doi: 10.1111/j.1365-2885.2012.01404.x. Epub 2012 May 8.

引用本文的文献

1
PEGylated Asparaginase in Children with Acute Lymphoblastic Leukemia Treated within the AIEOP-BFM ALL 2009 Trial: Population Pharmacokinetics and Drug Exposure.在AIEOP - BFM ALL 2009试验中接受治疗的急性淋巴细胞白血病儿童中的聚乙二醇化天冬酰胺酶:群体药代动力学与药物暴露情况
Eur J Drug Metab Pharmacokinet. 2025 Aug 19. doi: 10.1007/s13318-025-00962-3.
2
Dosing prediction of valproic acid in pediatric patients with epilepsy: population pharmacokinetic model or machine learning model?癫痫患儿丙戊酸的剂量预测:群体药代动力学模型还是机器学习模型?
Eur J Clin Pharmacol. 2025 Jul 5. doi: 10.1007/s00228-025-03874-y.
3
Model-Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations.
接受异基因造血干细胞移植的儿童和成人中白消安的模型引导精准给药:对当前药代动力学模型和剂量建议的批判性评估
Clin Pharmacol Ther. 2025 Sep;118(3):723-734. doi: 10.1002/cpt.3748. Epub 2025 Jun 22.
4
External evaluation of intravenous vancomycin population pharmacokinetic models in adults receiving high-flux intermittent haemodialysis.接受高通量间歇性血液透析的成人静脉注射万古霉素群体药代动力学模型的外部评估。
Br J Clin Pharmacol. 2025 Mar;91(3):856-865. doi: 10.1111/bcp.16334. Epub 2024 Nov 9.
5
Evaluation of the predictive performance of an online voriconazole dose calculator in children.评估在线伏立康唑剂量计算器在儿童中的预测性能。
Eur J Clin Pharmacol. 2024 Dec;80(12):1989-1993. doi: 10.1007/s00228-024-03762-x. Epub 2024 Sep 26.
6
Vancomycin in Pediatric Patients with Cystic Fibrosis: Dose Optimization Using Population Pharmacokinetic Approach.万古霉素在囊性纤维化儿科患者中的应用:基于群体药代动力学方法的剂量优化。
Eur J Drug Metab Pharmacokinet. 2024 Nov;49(6):677-687. doi: 10.1007/s13318-024-00913-4. Epub 2024 Sep 16.
7
Does Sample Size, Sampling Strategy, or Handling of Concentrations Below the Lower Limit of Quantification Matter When Externally Evaluating Population Pharmacokinetic Models?当对外评估群体药代动力学模型时,样本量、采样策略或低于定量下限浓度的处理是否重要?
Eur J Drug Metab Pharmacokinet. 2024 Jul;49(4):419-436. doi: 10.1007/s13318-024-00897-1. Epub 2024 May 5.
8
Population Pharmacokinetics and Pharmacogenetics Analyses of Dasatinib in Chinese Patients with Chronic Myeloid Leukemia.达沙替尼在中国慢性髓性白血病患者中的群体药代动力学和药物遗传学分析。
Pharm Res. 2023 Oct;40(10):2413-2422. doi: 10.1007/s11095-023-03603-z. Epub 2023 Sep 19.
9
External validation of population pharmacokinetic models of vancomycin in postoperative neurosurgical patients.术后神经外科患者万古霉素群体药动学模型的外部验证。
Eur J Clin Pharmacol. 2023 Aug;79(8):1031-1042. doi: 10.1007/s00228-023-03511-6. Epub 2023 Jun 1.
10
Systematic Evaluation of Pharmacokinetic Models for Model-Informed Precision Dosing of Meropenem in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.系统评价模型指导下的重症患者连续肾脏替代治疗时美罗培南精准给药的药代动力学模型。
Antimicrob Agents Chemother. 2023 May 17;67(5):e0010423. doi: 10.1128/aac.00104-23. Epub 2023 May 1.